Judging MR Simulation Procedures: A Phase I-II Study of the Use of Magnetic Resonance Imaging Simulation in the Planning of Radiation Treatments (JUMP)

ENROLLING
Protocol # :
19-759
Conditions
Prostate Cancer
Recurrent Adenocarcinoma
Liver Cancer
Head and Neck Cancer
Phase
I/II
Disease Sites
Lip, Oral Cavity and Pharynx
Esophagus
Liver
Larynx
Soft Tissue
Prostate
Eye and Orbit
Principal Investigator
Mak, Raymond

Trial Description

This is a master protocol for a prospective Phase I-II study evaluating feasibility and
efficacy of incorporating magnetic resonance imaging (MRI) simulation into the planning of
radiation treatments.

Eligibility Requirements

Inclusion Criteria:

- Participants must have a confirmed malignancy requiring radiation therapy.

- Age: 18 years or older

- ECOG performance status ≤2 (Karnofsky ≥60%, see Appendix A)

- Ability to understand and the willingness to sign a written informed consent document.

- Disease-specific eligibility criteria will be specified in the appropriate
subprotocol.

Exclusion Criteria:

- For MRI involving contrast, history of allergic reactions attributed to gadolinium
based IV contrast. Note: If patient will not receive contrast, this is not applicable

- Participants who cannot undergo an MRI

- Disease-specific exclusion criteria will be specified in the appropriate subprotocol

19-759